BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35102541)

  • 1. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway.
    Guo A; Fang G; Lin Z; Zheng S; Zhuang Z; Lin R; Lin Y
    Histol Histopathol; 2022 Jun; 37(6):543-554. PubMed ID: 35102541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
    Ding H; Cui L; Wang C
    Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-κB Signaling Pathway.
    Wu DM; Han XR; Wen X; Wang S; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
    Cell Physiol Biochem; 2018; 48(4):1563-1578. PubMed ID: 30071522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for hypoxia
    Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
    Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
    BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma.
    Liu T; Hu J; Han B; Tan S; Jia W; Xin Y
    Cell Death Dis; 2021 Oct; 12(11):952. PubMed ID: 34657141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
    Zhang L; Wang Y; Su H
    Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
    Hu YH; Jiao BH; Wang CY; Wu JL
    CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-146b-5p/EPHA7 axis regulates cell invasion, metastasis, proliferation, and temozolomide-induced chemoresistance via regulation of IRAK4/TRAF6/NF-κB signaling pathway in aggressive pituitary adenoma.
    Lou X; Cai Y; Zheng H; Zhang Y
    Histol Histopathol; 2022 Jan; 37(1):21-33. PubMed ID: 34746996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.
    Oliva CR; Halloran B; Hjelmeland AB; Vazquez A; Bailey SM; Sarkaria JN; Griguer CE
    Cell Commun Signal; 2018 Sep; 16(1):61. PubMed ID: 30231881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
    Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
    Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.
    Ye T; Chen R; Zhou Y; Zhang J; Zhang Z; Wei H; Xu Y; Wang Y; Zhang Y
    Bioengineered; 2022 May; 13(5):11646-11655. PubMed ID: 35505656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
    Yin H; Cui X
    Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
    [No Abstract]   [Full Text] [Related]  

  • 15. lncRNA MEG3 Inhibits the Proliferation and Growth of Glioma Cells by Downregulating Bcl-xL in the PI3K/Akt/NF-
    Jia H; Yan X
    Biomed Res Int; 2022; 2022():3729069. PubMed ID: 35860793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation.
    Xu HB; Chen XZ; Yu ZL; Xue F
    J Ethnopharmacol; 2023 Jan; 301():115855. PubMed ID: 36280019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma.
    Zhou J; Xu N; Liu B; Wang C; He Z; Lenahan C; Tang W; Zeng H; Guo H
    Cancer Sci; 2022 Aug; 113(8):2681-2692. PubMed ID: 35637600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451.
    Liu B; Cao W; Ma H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2507-2515. PubMed ID: 31213092
    [No Abstract]   [Full Text] [Related]  

  • 19. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
    Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
    J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.